| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 206 |
| 1 | ADALIMUMAB | 184 |
| 2 | METHOTREXATE | 175 |
| 3 | CLOZAPINE | 142 |
| 4 | INFLIXIMAB | 123 |
| 5 | FOLIC ACID | 112 |
| 6 | ASPIRIN | 111 |
| 7 | PREDNISONE | 108 |
| 8 | ASPIRIN 325 MG | 105 |
| 9 | ASPIRIN 81 MG | 105 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOTORASIB | 25 | 0.0072 |
| 1 | BRIGATINIB | 15 | 0.0041 |
| 2 | ERLOTINIB HYDROCHLORIDE | 51 | 0.0041 |
| 3 | MEGESTROL ACETATE | 9 | 0.0023 |
| 4 | PEMETREXED DISODIUM | 69 | 0.0018 |
| 5 | DALTEPARIN SODIUM | 18 | 0.0017 |
| 6 | VINORELBINE | 11 | 0.0016 |
| 7 | APREPITANT | 11 | 0.0015 |
| 8 | ABACAVIR SULFATE | 14 | 0.0014 |
| 9 | AFATINIB | 9 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 304 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 250 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 231 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 211 |
| 4 | Atypical Antipsychotic [EPC] | 161 |
| 5 | Benzodiazepine [EPC] | 145 |
| 6 | Vitamin C [EPC] | 136 |
| 7 | Platinum-based Drug [EPC] | 133 |
| 8 | Vitamin B12 [EPC] | 124 |
| 9 | Proton Pump Inhibitor [EPC] | 123 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 1 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 5 | 0.0015 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 12 | 0.0014 |
| 3 | Tyrosine Kinase 2 Inhibitor [EPC] | 3 | 0.0010 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 4 | 0.0008 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 12 | 0.0008 |
| 6 | Cannabinoid [EPC] | 6 | 0.0007 |
| 7 | alpha-Glucosidase Inhibitor [EPC] | 3 | 0.0006 |
| 8 | Antifibrinolytic Agent [EPC] | 6 | 0.0006 |
| 9 | Parenteral Iron Replacement [EPC] | 8 | 0.0006 |